Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Institutional Ownership : 5.37% (As of Jun. 22, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Cotinga Pharmaceuticals Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cotinga Pharmaceuticals's institutional ownership is 5.37%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cotinga Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cotinga Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 0.00%.

Cotinga Pharmaceuticals Institutional Ownership Historical Data

The historical data trend for Cotinga Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cotinga Pharmaceuticals Institutional Ownership Chart

Cotinga Pharmaceuticals Historical Data

The historical data trend for Cotinga Pharmaceuticals can be seen below:

	2011-07-31	2011-08-31	2011-09-30	2011-10-31	2011-11-30	2011-12-31	2012-01-31	2012-02-29	2012-03-31	2012-04-30
Institutional Ownership	6.40	6.40	6.40	6.33	6.33	6.33	6.33	6.33	6.33	5.37

Cotinga Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cotinga Pharmaceuticals Inc (OTCPK:COTQF) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C1P1

Website

http://www.cotingapharma.com

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Headlines

From GuruFocus

Cotinga Pharmacueticals Announces Closing of Unit Offering

By GlobeNewswire GlobeNewswire • 05-22-2019

Cotinga Pharmaceuticals Reports Fiscal 2018 Third Quarter Financial and Operating Results

By GlobeNewswire GlobeNewswire • 04-03-2018